4D Molecular Therapeutics, Inc. — 10-Q Filings
15 10-Q filings on record
This page lists all 10-Q filings submitted to the SEC by 4D Molecular Therapeutics, Inc. (FDMT), sorted by most recent first. Each row links to the full filing on EdgarLookup. 4D Molecular Therapeutics, Inc. has filed 15 10-Q documents with the SEC since 2015. To view all SEC filings by 4D Molecular Therapeutics, Inc., see the full filings list.
All
10-K
10-Q
144
144/A
3
3/A
4
424B4
424B5
8-A12B
8-K
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DRS
DRS/A
EFFECT
FWP
POS AM
POSASR
RW
S-1
S-1/A
S-1MEF
S-3
S-3ASR
S-8
S-8 POS
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 10-Q | 10-Q | 0001193125-25-273343 | Nov 10, 2025 | Sep 30, 2025 |
| 10-Q | 10-Q | 0000950170-25-106244 | Aug 11, 2025 | Jun 30, 2025 |
| 10-Q | 10-Q | 0000950170-25-067040 | May 8, 2025 | Mar 31, 2025 |
| 10-Q | 10-Q | 0000950170-24-126370 | Nov 13, 2024 | Sep 30, 2024 |
| 10-Q | 10-Q | 0000950170-24-094010 | Aug 8, 2024 | Jun 30, 2024 |
| 10-Q | 10-Q | 0000950170-24-056933 | May 9, 2024 | Mar 31, 2024 |
| 10-Q | 10-Q | 0000950170-23-062103 | Nov 9, 2023 | Sep 30, 2023 |
| 10-Q | 10-Q | 0000950170-23-040661 | Aug 9, 2023 | Jun 30, 2023 |
| 10-Q | 10-Q | 0000950170-23-020703 | May 11, 2023 | Mar 31, 2023 |
| 10-Q | 10-Q | 0000950170-22-023185 | Nov 8, 2022 | Sep 30, 2022 |
| 10-Q | 10-Q | 0000950170-22-016882 | Aug 11, 2022 | Jun 30, 2022 |
| 10-Q | 10-Q | 0000950170-22-009702 | May 12, 2022 | Mar 31, 2022 |
| 10-Q | 10-Q | 0000950170-21-004086 | Nov 10, 2021 | Sep 30, 2021 |
| 10-Q | 10-Q | 0001564590-21-043998 | Aug 12, 2021 | Jun 30, 2021 |
| 10-Q | 10-Q | 0001564590-21-027576 | May 13, 2021 | Mar 31, 2021 |